Evidence map›Paper›PMID 24914121›Full record

ArticleAntimicrobial agents and chemotherapy2014

Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settings.

Tracy H Hazen, LiCheng Zhao, Mallory A Boutin, Angela Stancil, Gwen Robinson, Anthony D Harris, David A Rasko, J Kristie Johnson

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Carbapenem-ResistantMicroorganisms · 2026
    Review
  4. Review
  5. Evolution of ceftazidime/avibactam resistance and plasmid dynamics in OXA-48-producing Klebsiella spp. during long-term patient colonization.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  6. Assessing the threat ofAntimicrobial agents and chemotherapy · 2025
    Article
  7. Genomic Analysis of ESBL-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tracy H HazenInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
LiCheng ZhaoDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Mallory A BoutinDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Angela StancilDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Gwen RobinsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Anthony D HarrisDivision of Genomic Epidemiology and Clinical Outcomes, Department of Epidemiology and Public Health, Baltimore, Maryland, USA.
David A RaskoInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
J Kristie JohnsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA JKJohnson@som.umaryland.edu.
University of Maryland, Baltimore · US

Funding

Clinical Research Career Development (RMI)K12RR023250 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2005 to 2009
$13.3M
Epidemiology of imipenem-resistant P.aeruginosaR01AI060859 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRIS, ANTHONY D · 2005 to 2013
$1.9M
K24 Clinical Research in Antimicrobial Resistance and Hospital EpidemiologyK24AI079040 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRIS, ANTHONY D · 2009 to 2018
$1.8M
NCRR NIH HHS K12 RR023250NCRR NIH HHS K12RR023250NIAID NIH HHS 1K24AI079040-01A1NIAID NIH HHS 2R01AI060859-05NIAID NIH HHS K24 AI079040NIAID NIH HHS R01 AI060859
6 · The paper itself

Abstract

The IncA/C plasmids have been implicated for their role in the dissemination of β-lactamases, including gene variants that confer resistance to expanded-spectrum cephalosporins, which are often the treatment of last resort against multidrug-resistant, hospital-associated pathogens. A bla(FOX-5) gene was detected in 14 Escherichia coli and 16 Klebsiella isolates that were cultured from perianal swabs of patients admitted to an intensive care unit (ICU) of the University of Maryland Medical Center (UMMC) in Baltimore, MD, over a span of 3 years. Four of the FOX-encoding isolates were obtained from subsequent samples of patients that were initially negative for an AmpC β-lactamase upon admission to the ICU, suggesting that the AmpC β-lactamase-encoding plasmid was acquired while the patient was in the ICU. The genomes of five E. coli isolates and six Klebsiella isolates containing bla(FOX-5) were selected for sequencing based on their plasmid profiles. An ∼ 167-kb IncA/C plasmid encoding the FOX-5 β-lactamase, a CARB-2 β-lactamase, additional antimicrobial resistance genes, and heavy metal resistance genes was identified. Another FOX-5-encoding IncA/C plasmid that was nearly identical except for a variable region associated with the resistance genes was also identified. To our knowledge, these plasmids represent the first FOX-5-encoding plasmids sequenced. We used comparative genomics to describe the genetic diversity of a plasmid encoding a FOX-5 β-lactamase relative to the whole-genome diversity of 11 E. coli and Klebsiella isolates that carry this plasmid. Our findings demonstrate the utility of whole-genome sequencing for tracking of plasmid and antibiotic resistance gene distribution in health care settings.

Indexed as

Genome, BacterialAdultAgedAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCephalosporinsDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsFemaleGene ExpressionGenetic VariationHumansIntensive Care UnitsKlebsiella InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase FOX-5beta-LactamasesCephalosporinsIncA protein, bacteriaPhosphoproteins

Identifiers

PMID24914121
PMCPMC4135983
OpenAlexW2048554948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.